• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Oct 16, 2020
Product Development

Recent Phase III disappointment aside, the heart failure pipeline holds plenty to look forward to

Drug development for heart failure is picking up, with five clinical readouts from five mechansims expected in the next year
Read More
BioCentury | Jul 18, 2016
Clinical News

QGC101: Phase IIa started

Read More
BioCentury | Aug 17, 2015
Company News

Quantum Genomics, University of Ottawa, Institut National de la Sante et de la Recherche Medicale deal

Read More
Items per page:
1 - 3 of 3